drugset
drugset / Trial / NCT02135965

Testing Potential Synergistic Effects of Albuterol and Caffeine on Metabolic Rate

NCT02135965 ↗

Phase 0 Completed 8 enrolled Pennington Biomedical Research Center
RandomizedCrossoverDouble-blindBasic science

Summary

The purpose of this study is to define a ratio of Caffeine and albuterol that gives a synergistic increase in metabolic rate.

Timeline

Start
2009-04
Primary completion
2011-08
Completion
2011-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Caffeine Small molecule 100 mg Oral
Subject Caffeine Small molecule 200 mg Oral
Subject Salbutamol Unknown 2 mg Oral
Subject Salbutamol Unknown 4 mg Oral

Indications

No indication recorded.